Med Clin North Am. 2023 Sep;107(5):861-882. doi: 10.1016/j.mcna.2023.05.006. Epub 2023 Jun 26.
ABSTRACT
Venous thromboembolism (VTE) is a common vascular disorder encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE). There is no data on global estimates of VTE prevalence and incidence. Most patients with unprovoked VTE require secondary thromboprophylaxis upon the completion of the primary treatment phase if they have no high bleeding risk. Risk prediction models can help identify patients at low VTE recurrence risk who may discontinue anticoagulation upon the completion of the primary treatment phase.
PMID:37541713 | DOI:10.1016/j.mcna.2023.05.006